MCI | Mild AD | Moderate AD | Severe AD | Drop-out | |
---|---|---|---|---|---|
Baseline (t1) | First Follow-up (t2) | ||||
MCI (n = 64) | 44 (68.8%) | 13 (20.3%) | 0 (0%) | 0 (0%) | 7 (10.9%) |
First Follow-up (t2) | Second Follow-up (t3) | ||||
MCI (n = 44) | 38 (86.4%) | 6 (13.6%) | 0 (0%) | 0 (0%) | 0 (0%) |
Mild AD (n = 13) | 0 (%) | 10 (76.9%) | 2 (15.4%) | 0 (0%) | 1 (7.7%) |
Second Follow-up (t3) | Third Follow-up (t4) | ||||
MCI (n = 38) | 32 (84.2%) | 4 (10.5%) | 1 (2.6%) | 0 (%) | 1 (2.6%) |
Mild AD (n = 16) | 0 (%) | 11 (68.6%) | 2 (12.5%) | 1 (6.3%) | 2 (12.5%) |
Moderate AD (n = 2) | 0 (%) | 0 (%) | 0 (%) | 2 (100%) | 0 (%) |
Baseline (t1) | Third Follow-up (t4) | ||||
MCI (n = 64) | 32 (50%) | 15 (23.4%) | 3 (4.7%) | 3 (4.7%) | 11 (17.2%) |